| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |